Acute Porphyria Drug Database

Monograph

C07AB09 - Esmolol
Not porphyrinogenic
NP

Rationale
Beta-blocker. Non-CYP metabolism. Two references: use.
Chemical description
Beta-receptor blocking agent. Metabolized by esterase in the red blood cells, the metabolite excreted in urine. South African list: use. EPI: safe (betablockers).
Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AB or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Brevibloc · Esmolol Brevibloc Brevibloc Brevibloc Brevibloc Concentrate · Brevibloc Premixed · Esmolol · Esmolol hydrochloride Brevibloc Brevibloc Esmocard Brevibloc Brevibloc
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙